论文部分内容阅读
目的研究前列地尔注射液对于急性肾功能衰竭的临床治疗效果。方法 180例急性肾功能衰竭患者,根据病历号尾数分为研究组(86例)和对照组(94例)。两组均采取常规治疗措施,对照组在此基础上应用黄芪注射液治疗,研究组在此基础上应用前列地尔进行治疗。对两组的疗效及安全性进行分析。结果研究组患者的治疗总有效率为95.29%,显著高于对照组的82.98%(P<0.05);治疗后研究组血清尿素氮(BUN)水平为(226.4±49.5)mmol/L、血清肌酐(Scr)为(12.1±3.7)μmol/L,均优于对照组的(382.6±61.3)mmol/L、(13.7±4.1)μmol/L(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。结论前列地尔注射液对于急性肾功能衰竭的效果好,安全性高,具有很高的推广价值。
Objective To study the clinical effect of alprostadil injection on acute renal failure. Methods One hundred and eighty patients with acute renal failure were divided into study group (86 cases) and control group (94 cases) according to their mantissa numbers. The two groups were taking conventional treatment measures, the control group on the basis of the application of Astragalus injection, the study group on the basis of the application of alprostadil for treatment. The efficacy and safety of the two groups were analyzed. Results The total effective rate of the study group was 95.29%, which was significantly higher than that of the control group (82.98%, P <0.05). After treatment, the level of serum urea nitrogen (BUN) was (226.4 ± 49.5) mmol / L, (12.1 ± 3.7) μmol / L, respectively, which were significantly higher than those in the control group (382.6 ± 61.3 mmol / L, 13.7 ± 4.1 μmol / L, P <0.05) No statistical significance (P> 0.05). Conclusion Alprostadil injection for acute renal failure with good effect, high safety, with a high promotional value.